Hadron Therapy and Grids: Issues and Requirements Ken Peach (Particle Therapy Cancer Research Institute, Oxford) EGI Technical Forum Amsterdam, September.

Slides:



Advertisements
Similar presentations
بسم الله الرحمن الرحيم ﴿و قل رب زدنى علماً﴾ صدق الله العظيم.
Advertisements

Success factors in grant applications and research projects: seminar.
“ Handle with Care” A GP guide to cancer care for elderly patients.
Radiotherapeutic Option in Management of Hepatocellular Carcinoma
Research Protocol ACRIN 6678 Learning About PET/CT Scans: Can PET/CT scans provide helpful information for the treatment of non-small cell lung cancer?
Consent for Research Study A study for patients newly diagnosed with advanced glioblastoma (brain cancer): Learning whether a PET scan with F-fluoromisonidazole.
Advances in Early Diagnosis and Treatment of Cancer July 17, 2007.
Radiation Protection in Radiotherapy
Radiotherapy for Brain Tumours What do I need to know? Dr Matthew Foote Radiation Oncologist Princess Alexandra Hospital Queensland.
The Health Roundtable 1-1b_HRT1215-Session_HEGI_JOHNSON_WESTMEAD_NSW Volumetric Modulated Arc Therapy for Stereotactic Body Radiotherapy in Early Lung.
Radiotherapy for Kidney cancer
Research-driven data standards CIMI 11 th April 2013.
ASCO Presentation Summary: Chemotherapy Treatment Plan and Summary Templates as a Component of Comprehensive Cancer Care Kansas Cancer Partnership University.
Hypofractionated Radiation Therapy for Early Stage Breast Cancer Patrick J. Gagnon, M.D. Resident, PGY-4 Radiation Medicine, OHSU Providence Hospital Breast.
Dr. Rico Liu Consultant, Department of Clinical Oncology, Queen Mary Hospital Honorary Clinical Associate Professor, Department of Clinical Oncology, The.
PAMELA Contact Author: CONFORM is an RCUK-funded Basic Technology Programme Charged Particle Therapy Treating cancer with protons and light ions Ken Peach,
ACRIN 6671/GOG 0233 Consent for Research Study A study for Women with Advanced Cervical Cancer: Learning whether a PET/CT scan using an imaging agent called.
Choice of chemotherapy in the treatment of metastatic squamous cell carcinoma of the anal canal. Eng C1, Rogers J2, Chang GJ3, You N3, Das P4, Rodriguez-Bigas.
1 Beyond coverage decisions: Private health plans in the US and comparative effectiveness research Steven D. Pearson, MD, MSc, FRCP President, Institute.
IT-DNG meeting, CERN , Motivation Project Overview Grid services Status Faustin Laurentiu Roman CERN / IFIC
National Oesophago–Gastric Cancer Audit Key Findings from 2014 Annual Report and Progress Report Georgina Chadwick Clinical Research Fellow.
TREATMENT PLANNING Modelling chemo-hadron therapy Lara Barazzuol | Valencia | 19 June 2009.
CTOS Soft Tissue Sarcoma of the Extremity Comparison of Conformal Post-operative Radiotherapy (CRT) and Intensity Modulated Radiotherapy (IMRT)
Clinico-Dosimetric Correlation for Acute and Chronic Gastrointestinal Toxicity in Patients of Locally Advanced Carcinoma Cervix Treated With Conventional.
BREAST MRI IN RADIATION THERAPY PLANNING MARSHA HALEY, M.D. ASSISTANT PROFESSOR UNIVERSITY OF PITTSBURGH CANCER INSTITUTE PITTSBURGH, PENNSYLVANIA, USA.
RIDE ConsortiumRIDE Workshop, December 8, 2006, Brussels 1 The RIDE Roadmap Methodology and the Current Progress Prof. Dr. Asuman Dogac, Turkey Dr. Jos.
Response of the sensors to different doses from tests in Israel Radiotherapy is used as a treatment in around 50% of cancer cases in the UK. Predominantly,
From Physics to Health applications: challenges and benefits Serbia Detector School, 13 September 2014 Manjit Dosanjh, CERN.
PROSTATE CANCER: RADIATION THERAPY APPROACHES ANDREW L. SALNER, MD FACR DIRECTOR HELEN & HARRY GRAY CANCER CENTER HARTFORD HOSPITAL, CT.
ENLIGHT- PARTNER Meeting, June 2009, IFIC- Valencia Manjit DOSANJH ENLIGHT Coordinator & CERN.
The KU Wichita Center for Breast Cancer Survivorship Judy Johnston, MS, RD/LD Research Instructor Department of Preventive Medicine and Public Health,
David Carr The Wellcome Trust Data management and sharing: the Wellcome Trust’s approach Economic & Social Data Service conference.
Linda Devereux Associate Director Merseyside and Cheshire Cancer Network - why we are here and what’s next!
Consent for Research Study A study for patients newly diagnosed with advanced glioblastoma (brain cancer): Learning whether a PET scan with F-fluoromisonidazole.
ACGT: Open Grid Services for Improving Medical Knowledge Discovery Stelios G. Sfakianakis, FORTH.
TPS & Simulations within PARTNER D. Bertrand, D. Prieels Valencia, SPAIN 19 JUNE 2009.
Cern.ch/knowledgetransfer. Knowledge Transfer | Accelerating Innovation Giovanni Anelli, CERN KT Training,
Stereotactic Ablative Body Radiotherapy for Non small cell lung cancer
Cancer.orgPredict Results of a multicentric in silico clinical trial (ROCOCO): comparing radiotherapy with photons and protons for non-small cell lung.
EGEE-II INFSO-RI Enabling Grids for E-sciencE EGEE and gLite are registered trademarks Ignacio Blanquer Vicente Hernández Damià.
Cern.ch/knowledgetransfer. Knowledge Transfer | Accelerating Innovation BE-KT Innovation Day,
ENLIGHT,12/2/20021 Health and Science, can CERN contribute? The Mission of CERN (1954): “The Organization shall provide for collaboration among European.
Introduction to Radiation Therapy
Faustin Laurentiu Roman, Daniel Abler, Vassiliki Kanellopoulos CERN IFIC, Univ. of Oxford, Univ. of Surrey HISP: a data-driven portal.
Flair development for the MC TPS Wioletta Kozłowska CERN / Medical University of Vienna.
Understanding Radiation Therapy
II PCI2009 IFIC Nov 2010 ENLIGHT and PARTNER Motivation Prototype and Usecases Tools, architecture & services Conclusions eReferral and eScience.
SARC018: A SARC PILOT MULTICENTER STUDY OF PREOPERATIVE RADIATION AND SURGERY IN PATIENTS WITH HIGH- RISK DESMOID TUMORS Robert S. Benjamin, M.D.
IFIC Grid Course, Valencia , Particle Therapy Motivation Project description Legal and ethical framework Status Faustin.
Atoms for Health Prof. Dr. Werner Burkart Skolkovo Conference on: Accelerators and Radiation Technologies for the Future of Russia Saint Petersburg,
Training for organisations participating in Peer Review of Paediatric Diabetes.
The Australian Hadron Therapy and Research Facility.
TRANSFoRm A flexible zone model for data privacy and confidentiality in medical research Wolfgang Kuchinke 1,Christian Ohmann, 1 Evert-Ben van Veen 2,
EUDAT receives funding from the European Union's Horizon 2020 programme - DG CONNECT e-Infrastructures. Contract No The use of the.
Developing and Implementing Intervention Studies Using Geriatric Assessment Supriya Gupta Mohile, M.D., M.S. Assistant Professor of Medicine James Wilmot.
Aim: Describe how new health care professionals are deployed
Omega Best Cancer Hospital - India
cyberknife®: can we cure pancreatic cancer?
IAEA E-learning Program
EURADOS Working Group 9: Radiation Dosimetry in Radiotherapy
Stage I Non Small Cell Lung Cancer (NSCLC): single centre comparison of outcome by treatment with surgery, conventional radiotherapy and stereotactic ablative.
Feasibility of hippocampal sparing radiation therapy for glioblastoma using helical Tomotherapy Dr Kamalram THIPPU JAYAPRAKASH1,2,3, Dr Raj JENA1,4 and.
Treatment With Continuous, Hyperfractionated, Accelerated Radiotherapy (CHART) For Non-Small Cell Lung Cancer (NSCLC): The Weston Park Hospital Experience.
Learning About PET/CT Scans:
Figure 2 Nonmalignant tissue can be spared from radiation
Figure 4 Treatment plans using stereotactic body radiotherapy (SBRT)
Figure 3 Clinical trial design in charged-particle therapy (CPT)
Regional radiotherapy and oncology network in SEE countries
Technical Advances of Radiation Therapy for Thymic Malignancies
MULTIDISCIPLINARY (MDT) APPROACH TO CLINICAL CARE MODEL FOR EFFECTIVE AND BEST EVIDENCE PATIENT CARE DR EZEKIEL ALAWALE MBBS, FWACS, FRCS(I), JCPTGP, GP.
Presentation transcript:

Hadron Therapy and Grids: Issues and Requirements Ken Peach (Particle Therapy Cancer Research Institute, Oxford) EGI Technical Forum Amsterdam, September 16 th 2010 on behalf of The ENLIGHT Network of EU projects

Ken Peach, EGI Technical Meeting, Amsterdam,16/9/ Outline Cancer– statistics and challenges ENLIGHT – research and development Cancer informatics – what is needed? – (how) can Grids help? – issues? Summary

Cancer Statistics and challenges

Ken Peach, EGI Technical Meeting, Amsterdam,16/9/ Cancer Statistics About one third of us will have cancer About two thirds of cancers are in people over 65 Source CRUK

Ken Peach, EGI Technical Meeting, Amsterdam,16/9/ Cancer - Information Cancer is a terrible condition but there have been great advances in therapy “ Radiotherapy remains a mainstay in the treatment of cancer. Comparison of the contribution towards cure by the major cancer treatment modalities shows that of those cured, 49% are cured by surgery, 40% by radiotherapy and 11% by chemotherapy”. RCR document BFCO(03)3, (2003). Radiotherapy is a very important weapon in the battle against cancer Thanks to Roger Dale

Ken Peach, EGI Technical Meeting, Amsterdam,16/9/ Photons, Protons and Carbon

Ken Peach, EGI Technical Meeting, Amsterdam,16/9/ X-rays compared with protons IMRT Intensity Modulated RadioTherapy IMPT Intensity Modulated Proton Therapy X-rays IMRTIMPT

Ken Peach, EGI Technical Meeting, Amsterdam,16/9/ Thanks to Raj Jena CPT is very effective proton matched with 1591 X-ray patients. 6.4% of proton patients had a second malignancy 12.8% of X-ray patients had a second malignancy [Median follow-up 7.7 years (proton) and 6.1 years (X-ray) Median age at treatment 56 (proton) and 59 (X-ray) ] (C.S. Chung et al, International Journal of Radiation Oncology*Biology*Physics, 72/1, Supplement 1 doi: /j.ijrobp )International Journal of Radiation Oncology*Biology*Physics72/1, Supplement 1 doi: /j.ijrobp Chordoma Dose Response Spinal cord tolerance 65Gy in 39 fractions Only protons/light ions can deliver the required 90Gy for good local control (D. Schulz-Ertner et al. Int J Radiat Oncol Biol Phys Jun 1;68(2):449-57)

Ken Peach, EGI Technical Meeting, Amsterdam,16/9/ CPT worldwide Courtesy Janet Sisterson, MGH In Physics Laboratories In hospitals

Ken Peach, EGI Technical Meeting, Amsterdam,16/9/ ENLIGHT Coordinated by CERN

Ken Peach, EGI Technical Meeting, Amsterdam,16/9/ ENLIGHT FP7 Projects

Cancer Informatics – what is needed? – (how) can Grids help? – issues?

Ken Peach, EGI Technical Meeting, Amsterdam,16/9/ Cancer Informatics what is needed? Cancer is very common –lung, breast, skin … … but … many rare tumours “rare” tumours make up 20% of all cancers tens or fewer each year in each country naturally distributed and multidisciplinary Cancer treatment is sophisticated –many options, many variables Maximise tumour control Minimise normal tissue toxicity and long-term complications Secondary tumours, organ function impairment

Ken Peach, EGI Technical Meeting, Amsterdam,16/9/ PARTNER GRID Test Bed Classes of use: –Clinical Patient referral (few centres, cross-border…) Treatment options (search for similar cases with treatment outcomes) –Research Access to statistical data –Treatment and outcomes –Training Treatment planning, research methodologies Example: Rare Tumour DataBase

Ken Peach, EGI Technical Meeting, Amsterdam,16/9/ Cancer Informatics (how) can Grids help? In order to allow rapid accumulation of evidence in trials, standard informatics systems are required so that data from different centres can be readily combined. This same system would underpin patient services, such as transnational referral. H adron therapy i I nformation S haring P latform Daniel Abler Faustin Laurentiu Roman Vassiliki Kanellopoulos [PARTNER]

Ken Peach, EGI Technical Meeting, Amsterdam,16/9/ Cancer Informatics – issues? 1. Authentication –Patient data –Confidentiality –Legal considerations –Ethical considerations Username/password & certificate not enough 2.Authorisation –Anonymity (research) –Full record (clinical) –Need to account for “Role” [Actor] Different authorisation according access –As doctor –As researcher

Ken Peach, EGI Technical Meeting, Amsterdam,16/9/ Cancer Informatics – issues (cont) 3.Data Ownership, Access, Integrity & Use –These data have a specific “owner” The patient If part of a clinical trial, the research team –Undesirable to make common real DB –Undesirable to make local copy Once copied, owner risks losing control –Note: does not apply to (a)Backup (b)Archiving (c)Cloning for security/integrity/availability −Data volumes can be large 10’s GB per patient with images (CT, MRI, PET, TP…) }

Ken Peach, EGI Technical Meeting, Amsterdam,16/9/ CT PET high-resolution structural information lower-resolution functional information PET-CT fuses two co-registered images (same coordinate system) Fusion helps identify position and extent of tumour Examples: multi-modal imaging Topkan et. al., J Exp Clin Cancer Res. 2008; 27(1): 41. Thanks to Dan Warren Imaging in different places/at different times complicated

Ken Peach, EGI Technical Meeting, Amsterdam,16/9/ Further comments Confidentiality, Anonymity & Trust –Clinical [Confidentiality] Confidentiality must be guaranteed –Note: the doctor, radiologist, medical physicist… can only access a patient record for a patient in their care –Research [Anonymity] Anonymity must be guaranteed –Where is anonymisation performed? »Can only be at source –Hospital policies [Trust] Many hospital IT policies are very restrictive –With good reason … the internet is a security risk

Ken Peach, EGI Technical Meeting, Amsterdam,16/9/ Common issues with other VOs Platform/infrastructure independence Middleware independence –Together “interoperability” Security and sustainability (Virtual) database definition & management Metadata, ontology & semantics Workflow Curation

Ken Peach, EGI Technical Meeting, Amsterdam,16/9/ Data Data Data Treatment Planning & Verification is computationally intenseBUT Cancer informatics is about Data! –Agreed data formats –Open data standards –Ergonomic GUIs –Service reliability –Data integrity –Data completeness

Ken Peach, EGI Technical Meeting, Amsterdam,16/9/ What do IBM think? Thanks to Faust Roman

Ken Peach, EGI Technical Meeting, Amsterdam,16/9/ ENLIGHT ENLIGHT: a multidisciplinary collaboration platform ENLIGHT: –300 persons, 20 countries The aim is to: – communicate – share data – collaborate and network – train and educate – improve and optimise – refer and treat patients – research and improve –real time imaging & quality assurance 4 funded projects: 3 ongoing ULICE ENVISION ULICE ENVISION PARTNER Thanks to Manjit Dosanjh

Ken Peach, EGI Technical Meeting, Amsterdam,16/9/ ENLIGHT addresses these issues

Ken Peach, EGI Technical Meeting, Amsterdam,16/9/ Summary Hadron Therapy and Grids Common requirements with other applications Specific issues concerned with patient data Confidentiality Security Authentication Authorisation Anonymisation Health system IT managers –Cautious Clinicians –Prefer the tried and trusted – what I know works